For more on David Nierengarten’s comments: Wedbush: Y-mAbs Could Attract Investor Attention As Market Volatility Grows
David Nierengarten: Y-mAbs Therapeutics Should be Particularly Attractive for Investors.
For more on David Nierengarten’s comments: Wedbush: Y-mAbs Could Attract Investor Attention As Market Volatility Grows